Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 144

Similar articles for PubMed (Select 8978287)

1.
2.
3.

Cytokine-facilitated transduction leads to low-level engraftment in nonablated hosts.

Kittler EL, Peters SO, Crittenden RB, Debatis ME, Ramshaw HS, Stewart FM, Quesenberry PJ.

Blood. 1997 Jul 15;90(2):865-72.

5.

Retrovirus-mediated transfer of the multidrug resistance gene into human haemopoietic progenitor cells.

Bertolini F, de Monte L, Corsini C, Lazzari L, Lauri E, Soligo D, Ward M, Bank A, Malavasi F.

Br J Haematol. 1994 Oct;88(2):318-24.

PMID:
7803276
6.

Improved retroviral vectors for hematopoietic stem cell protection and in vivo selection.

Baum C, Eckert HG, Stockschläder M, Just U, Hegewisch-Becker S, Hildinger M, Uhde A, John J, Ostertag W.

J Hematother. 1996 Aug;5(4):323-9. Review.

PMID:
8877707
7.
9.
10.

Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.

Gehling UM, Ryder JW, Hogan CJ, Hami L, McNiece I, Franklin W, Williams S, Helm K, King J, Shpall EJ.

Exp Hematol. 1997 Oct;25(11):1125-39.

PMID:
9328449
11.

FLT3 ligand preserves the uncommitted CD34+CD38- progenitor cells during cytokine prestimulation for retroviral transduction.

Nielsen SD, Husemoen LL, Sørensen TU, Gram GJ, Hansen JE.

J Hematother Stem Cell Res. 2000 Oct;9(5):695-701.

PMID:
11091493
12.

Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients.

Cowan KH, Moscow JA, Huang H, Zujewski JA, O'Shaughnessy J, Sorrentino B, Hines K, Carter C, Schneider E, Cusack G, Noone M, Dunbar C, Steinberg S, Wilson W, Goldspiel B, Read EJ, Leitman SF, McDonagh K, Chow C, Abati A, Chiang Y, Chang YN, Gottesman MM, Pastan I, Nienhuis A.

Clin Cancer Res. 1999 Jul;5(7):1619-28.

13.

Gene transfer of multidrug resistance into a factor-dependent human hematopoietic progenitor cell line: in vivo model for genetically transferred chemoprotection.

Schwarzenberger P, Spence S, Lohrey N, Kmiecik T, Longo DL, Murphy WJ, Ruscetti FW, Keller JR.

Blood. 1996 Apr 1;87(7):2723-31.

14.

Transduction of MDR1 into human and mouse haemopoietic progenitor cells: use of rhodamine (Rh123) to determine transduction frequency and in vivo selection.

Hegewisch-Becker S, Hanania EG, Fu S, Körbling M, Deisseroth AB, Andreeff M.

Br J Haematol. 1995 Aug;90(4):876-83.

PMID:
7669666
15.

Marrow sensitization to 5-fluorouracil using the ligands for Flt-3 and c-Kit.

Jin L, Neff T, Blau CA.

Exp Hematol. 1999 Mar;27(3):520-5.

PMID:
10089915
16.
17.

Effect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in vivo and in vitro.

Song H, Vita M, Sallam H, Tehranchi R, Nilsson C, Sidén A, Hassan Z.

Cancer Chemother Pharmacol. 2007 Nov;60(6):841-9. Epub 2007 Feb 22.

PMID:
17318617
18.

Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91.

Sugimoto Y, Tsukahara S, Sato S, Suzuki M, Nunoi H, Malech HL, Gottesman MM, Tsuruo T.

J Gene Med. 2003 May;5(5):366-76.

PMID:
12731085
19.

Introduction of the green fluorescent protein gene into hematopoietic stem cells results in prolonged discrepancy of in vivo transduction levels between bone marrow progenitors and peripheral blood cells in nonhuman primates.

Hanazono Y, Terao K, Shibata H, Nagashima T, Ageyama N, Asano T, Ueda Y, Kato I, Kume A, Hasegawa M, Ozawa K.

J Gene Med. 2002 Sep-Oct;4(5):470-7.

PMID:
12221639
20.

Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability.

Tisdale JF, Hanazono Y, Sellers SE, Agricola BA, Metzger ME, Donahue RE, Dunbar CE.

Blood. 1998 Aug 15;92(4):1131-41.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk